AboutLifeTree
About Lifetree - Who We Are Our Philosophy Executive Management Team: Alice A. Jackson, R.N. Lynn R. Webster, MD, FACPM, FASAM Matthew Iverson Sean Kotrady, CCRC, CCRP Neuroscience Research Team: Miroslav "Misha" Bačkonja, MD Mark A. Johnston, MD N. Lee Smith, MD Daniel B. Vine, MD Mary Jane Norman, MD Dennis Thoen, MD Debra F. Hobbins, DNP, APRN, LSAC, CARN-AP
ClinicalResearch
THERAPEUTIC EXPERTISE Clinical Research Abstracts Abuse Liability Analgesia Pain Model Development Lifetree Center for Neuroscience Research Phase 1 Research Sleep Medicine Ophthalmology
Clinical TrialManagement
Clinical Trial Management Data Management Services Interactive Voice Response System Medical and Safety Management Medical Writing Biostatistics and Analysis Services Drug Development Services
PressRoom
Press Releases & News Media Coverage Research Articles Calendar of Events
ContactLifeTree
Contact Lifetree Employment Opportunities For Study Participants For Biopharmaceutical and Device Clients Physicians: Become a Lifetree Investigator
VolunteerFor a Study
Volunteer - Screening Survey Current Research Studies Clinical Research Studies: Alzheimer's Clinical Trial Bunion Removal Chlamydia Home Testing Kit Chronic Pain Chronic Pain from Post-Herpetic Neuralgia Depression Clinical Trial Diabetic Peripheral Neuropathy Drug Abuse Study - Recreational use of Prescription Medications Gonorrhea Home Testing Kit Healthy Males and Females Healthy Seniors Hepatitis C Clinical Trial High Blood Pressure Hypertension Low Back Pain Mild Dementia Migraine Headaches Multiple Sclerosis Opioid Induced Constipation Osteoarthritis of the Hip and or Knee Schizophrenia Clinical Trial Sciatica Suboxone Wisdom Teeth Removal

Media Coverage

< back to Media Coverage

Date: Jan 15 2010

Dr Webster speaks on Emerging Solutions in Pain: How Often do you Order Urine Drug Tests?
Lynn R. Webster, MD, FACPM, FASAM
Co-founder and Medical Director
Lifetree Clinical Research
Salt Lake City, Utah
 
 
I am often asked how often we should perform urine drug tests. Well, my response is
that today we probably need to perform urine drug tests far more than we have in the
past. I think that it is becoming a standard of care in patients that are receiving chronic
opioid therapy. I order urine drug tests on all new patients to my clinic. I have a tertiary
center, but I think individuals who are going to be placed on chronic opioid therapy
should probably routinely have urine drug tests at least annually and in anyone who
displays aberrant behaviors, there probably should be a repeat urine drug test. The
urine drug test is probably the single best diagnostic tool to help detect aberrant
behaviors if it’s not observed by you as the clinician or by your staff.